Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

DOI Full Paper Access

46

Citations

16

References

2023

Year

Marius Trøseid, José Ramón Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, Vida Terzić, Fulvia Mazzaferri, Jesús Rodríguez‐Baño, Joe Eustace, Maya Hites,

References

	Year	Citations

Page 1